AI IntelligenceMay 22, 2026Secondary Market
Article
TPST
Tempest Therapeutics, Inc. received a delisting notice from Nasdaq and has filed an 8-K disclosing the event. The company may seek to regain compliance.
Data Cube AI EditorialSource: SEC EDGAR
01
Source Brief
Tempest Therapeutics, Inc. received a delisting notice from Nasdaq and has filed an 8-K disclosing the event. The company may seek to regain compliance.
02